On Thursday, MRC Global Inc. (NYSE:MRC)’s shares climbed, after MRC Global declared that its U.S. partner, McJunkin Red Man Corporation (MRC), has been awarded a three-year integrated supply contract with the largest combined oil and gas producer in California. This contract covers all project requirements, maintenance, repair and operations (MRO) supplies and the managing of all materials located at the largest oil and gas warehouse facility in the San Joaquin Basin.
With assets located exclusively in California, this customer is the state’s largest producer of oil and gas on a gross-operated basis with about 2.3 million net acres covering California’s four major oil and gas basins. Their Elk Hills Field is one of the largest oil and gas fields in the U.S. and supplies more than 40% of California’s gas production and 5% of the state’s oil production.
MRC Global Inc., through its auxiliaries, distributes pipes, valves, fittings, and related products and services to the energy and industrial sectors in the Unites States, Canada, and internationally. It offers ball, butterfly, gate, globe, check, needle, and plug valves; and other products, such as lined corrosion resistant piping systems, control valves, valve automation, and top work components, in addition to steam and instrumentation products.
Prothena Corporation plc (NASDAQ:PRTA)’s shares jumped during the last trading session on Thursday, after a late-stage clinical biotechnology corporation declared that it priced an underwritten public offering of 3,300,000 of its ordinary shares at a price to the public of $37.00 per ordinary share, before the underwriting discount. All of the ordinary shares in the offering were sold by Prothena. In addition, Prothena has granted the underwriters a 30-day option to purchase up to an additional 495,000 of its ordinary shares.
Net proceeds to Prothena from the ordinary shares to be sold by Prothena in the offering are predictable to be $114.2 million, after deducting the underwriting discount and estimated offering expenses, but not including any exercise of the underwriters` option to purchase additional ordinary shares. The offering is predictable to close on April 13, 2015, subject to customary closing conditions.
Credit Suisse, RBC Capital Markets and UBS Investment Bank are acting as joint book-running managers, and Oppenheimer & Co., Wedbush PacGrow, Ladenburg Thalmann and LifeSci Capital are acting as co-managers for the offering.
Prothena Corporation plc, a late-stage clinical biotechnology corporation, focuses on the discovery, development, and commercialization of protein immunotherapy programs for the treatment of diseases that involve amyloid or cell adhesion in Ireland.
At the end of Thursday’s trade, ConocoPhillips (NYSE:COP)’s shares climbed, after ConocoPhillips offered details of its financial priorities and operating plan at its Analyst and Investor Meeting in New York. Members of the corporation’s executive leadership team discussed ConocoPhillips’ aim to offer attractive annual returns to shareholders through a compelling dividend, predictable growth and a priority on margins and financial returns.
The corporation will also provide an update on first-quarter 2015 financial and operating results during a conference call webcast on Thursday, April 30, 2015 at 12:00 p.m. EDT. The corporation’s first-quarter earnings will be released before the market opens on April 30. A live webcast of the meeting will be made accessible on the ConocoPhillips Investor Relations site, www.conocophillips.com/investor.
ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids worldwide. Its portfolio comprises shale and oil sands assets; lower-risk legacy assets in North America, Europe, Asia, and Australia; various international developments; and exploration prospects. ConocoPhillips was founded in 1917 and is headquartered in Houston, Texas.
NuVasive, Inc. (NASDAQ:NUVA), ended its Thursday’s trading session in Green, after NuVasive declared that its first quarter 2015 earnings declaration will take place on Monday, May 4, 2015 after the close of the market.
NuVasive will hold a conference call on Monday, May 4, 2015 at 4:30 p.m. ET / 1:30 p.m. PT to talk about the results of its financial performance in the first quarter 2015. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers.
NuVasive, Inc., a medical device corporation, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its products focus on applications for spine fusion surgery.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
